ELI LILLY & Co (LLY) is a Health Care company in the Pharmaceutical Preparations industry (SEC CIK 0000059478). Annual revenue was $65.18B in FY2025, compared to $28.32B in FY2021. Net income in FY2025 was $20.64B (diluted EPS $22.95).
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 |
|---|
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-232707 | May 20, 2026 | May 20, 2026 | May 20, 2026 20:30 UTC | EDGAR |
| 8-K |
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| FY21Dec '21 |
|---|
| Revenue | $65.18B | $45.04B | $34.12B | $28.54B | $28.32B |
|---|---|---|---|---|---|
| Gross Profit | $54.13B | $36.63B | $27.04B | $21.91B | $21.01B |
| Operating Income | — | — | — | — | — |
| Net Income | $20.64B | $10.59B | $5.24B | $6.24B | $5.58B |
| EPS (Diluted) | $22.95 | $11.71 | $5.80 | $6.90 | $6.12 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $112.48B | $78.72B | $64.01B | $49.49B | $48.81B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $26.54B | $14.27B | $10.86B | $10.78B | $9.15B |
| Cash & Equivalents | $7.27B | $3.27B | $2.82B | $2.07B | $3.82B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $16.81B | $8.82B | $4.24B | $7.59B | $7.37B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 83.0% | 81.3% | 79.2% | 76.8% | 74.2% |
| Operating Margin | 0.4% | 0.5% | 0.5% | 0.5% | 0.5% |
| Net Margin | 0.5% | 0.5% | 0.6% | 0.5% | 0.6% |
| Return on Equity | 77.8% | 74.2% | 48.2% | 58.0% | 61.0% |
| Return on Assets | 18.4% | 13.5% | 8.2% | 12.6% | 11.4% |
| Debt / Equity | — | — | — | — | — |
| 0000059478-26-000048 |
| May 4, 2026 |
| May 7, 2026 |
| May 7, 2026 20:41 UTC |
| EDGAR |
| 8-K | 0000059478-26-000043 | Apr 30, 2026 | Apr 30, 2026 | Apr 30, 2026 11:03 UTC | EDGAR |
| 10-Q | 0000059478-26-000045 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 15:25 UTC | EDGAR |
| 10-K | 0000059478-26-000013 | Dec 31, 2025 | Feb 12, 2026 | Feb 12, 2026 18:58 UTC | EDGAR |
| 8-K | 0000059478-26-000008 | Feb 4, 2026 | Feb 4, 2026 | Feb 4, 2026 12:05 UTC | EDGAR |
| 8-K | 0000059478-25-000271 | Nov 18, 2025 | Nov 21, 2025 | Nov 21, 2025 21:19 UTC | EDGAR |
| 8-K | 0000059478-25-000251 | Oct 30, 2025 | Oct 30, 2025 | Oct 30, 2025 11:03 UTC | EDGAR |
Direct links to SEC EDGAR. LLY has additional filings available on the SEC site.
